<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01525862</url>
  </required_header>
  <id_info>
    <org_study_id>2091-001</org_study_id>
    <nct_id>NCT01525862</nct_id>
  </id_info>
  <brief_title>XprESS Maxillary Balloon Dilation Study</brief_title>
  <official_title>XprESS Maxillary Sinus Balloon Dilation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Entellus Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Entellus Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, single-arm, post approval pilot study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is evaluating transnasal sinus balloon dilation without tissue removal to treat&#xD;
      the maxillary sinuses in patients with sinusitis. The study will be assessing symptomatic&#xD;
      improvement post procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SNOT-20 Score</measure>
    <time_frame>Baseline and 6 months post procedure</time_frame>
    <description>The 20-item Sino-Nasal Outcomes Test (SNOT-20) is a validated patient-reported outcome measure for assessing the presence and severity of symptoms of chronic rhinosinusitis. Symptoms on the SNOT-20 survey are each rated on a scale from 0 (no problem) to 5 (problem as bad as it can be) and the 20 symptom scores are averaged to provide a total score ranging from 0 to 5. The minimal clinically important difference in the SNOT-20 has been determined to be a reduction greater or equal to 0.8 in the total SNOT-20 score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery Time</measure>
    <time_frame>1 week post procedure</time_frame>
    <description>Patient-reported time from procedure to ability to return to normal daily activities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Pain Scores</measure>
    <time_frame>Immediately post procedure</time_frame>
    <description>Procedure pain/discomfort on a scale of 0 (no pain) to 10 (severe pain) as reported by the participant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revision Rate</measure>
    <time_frame>6 Months post procedure</time_frame>
    <description>The number of participants who require revision sinus surgery during the study duration.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Chronic Sinusitis</condition>
  <condition>Chronic Rhinosinusitis (Diagnosis)</condition>
  <arm_group>
    <arm_group_label>Balloon sinus dilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Balloon dilation of the maxillary sinus using a transnasal approach.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Balloon sinus dilation</intervention_name>
    <arm_group_label>Balloon sinus dilation</arm_group_label>
    <other_name>XprESS Multi-Sinus Balloon Dilation Tool</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Be at least 18 years of age.&#xD;
&#xD;
          2. Must have uncomplicated sinusitis of the maxillary sinuses with or without anterior&#xD;
             ethmoid disease.&#xD;
&#xD;
          3. Meet EITHER the Anthem Coverage Guideline OR BlueCross BlueShield of North Carolina&#xD;
             Corporate Medical Policy for medically necessary functional endoscopic sinus surgery&#xD;
             (FESS) to treat uncomplicated sinusitis.&#xD;
&#xD;
          4. Have a CT scan within 6 months prior to enrollment.&#xD;
&#xD;
          5. Be mentally and physically capable (as per physician discretion) to participate in the&#xD;
             investigation.&#xD;
&#xD;
          6. Be willing and able to sign the study-specific informed consent prior to any&#xD;
             study-related procedures.&#xD;
&#xD;
          7. Be willing and able to undergo balloon dilation in the clinic setting.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Have evidence of posterior ethmoid, sphenoid or frontal sinus (excludes presence of&#xD;
             mucous retention cysts) disease requiring endoscopic sinus surgery or balloon&#xD;
             dilatation.&#xD;
&#xD;
          2. Have presence of features consistent with sinus fungal disease.&#xD;
&#xD;
          3. Have evidence of gross polypoid disease within any of the sinuses or within the&#xD;
             infundibulum.&#xD;
&#xD;
          4. Require concurrent nasal surgery (eg, septoplasty, turbinate reduction, etc).&#xD;
&#xD;
          5. Have previous sinus surgery (eg, sinus surgery or balloon sinuplasty).&#xD;
&#xD;
          6. Have nasal surgery (eg, septoplasty, turbinate reduction) performed within 3 months&#xD;
             prior to enrollment.&#xD;
&#xD;
          7. Have any anatomical anomaly (ie, severe septal deviation) preventing transnasal access&#xD;
             to the maxillary sinus outflow tract.&#xD;
&#xD;
          8. Have a history of primary ciliary dysfunction.&#xD;
&#xD;
          9. Have hemophilia.&#xD;
&#xD;
         10. Be currently undergoing, or have undergone in the past 6 months, chemotherapy for&#xD;
             cancer or radiation therapy in the head or neck region.&#xD;
&#xD;
         11. Have a history of cystic fibrosis.&#xD;
&#xD;
         12. Have Sampter's Triad (ie, defined as having all 3 of the following: aspirin&#xD;
             sensitivity, asthma, and sinonasal polyposis).&#xD;
&#xD;
         13. Have known sinonasal tumors or obstructive lesions.&#xD;
&#xD;
         14. Be pregnant at the time of enrollment.&#xD;
&#xD;
         15. Be unable to stop anticoagulant medication (eg, warfarin) until the International&#xD;
             Normalized Ratio (INR) is below 1.5.&#xD;
&#xD;
         16. Be unable to stop antiplatelet (eg, clopidogrel, aspirin, etc.) for at least 7 days&#xD;
             prior to study procedure.&#xD;
&#xD;
         17. Be currently participating in any other drug or device clinical studies excluding&#xD;
             postapproval or marketing registry studies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James D. Gould, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Synergy ENT Specialists</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Entellus Medical</name>
      <address>
        <city>Plymouth</city>
        <state>Minnesota</state>
        <zip>55447</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Synergy ENT Specialists</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.entellusmedical.com</url>
    <description>Sponsor website</description>
  </link>
  <link>
    <url>https://www.stlsinuscenter.com/wp-content/uploads/2018/04/In-Office-Balloon-Dilation.Procedue-Technique-and-Outcome-Dr.-James-D.-Gould-2-copy.pdf</url>
    <description>White paper with study results</description>
  </link>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>February 1, 2012</study_first_submitted>
  <study_first_submitted_qc>February 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2012</study_first_posted>
  <results_first_submitted>September 29, 2020</results_first_submitted>
  <results_first_submitted_qc>September 29, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 22, 2020</results_first_posted>
  <last_update_submitted>October 21, 2020</last_update_submitted>
  <last_update_submitted_qc>October 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Balloon sinus dilation</keyword>
  <keyword>Balloon catheters</keyword>
  <keyword>Sinuplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Balloon Sinus Dilation</title>
          <description>Balloon dilation of the maxillary sinus using a transnasal approach.&#xD;
Balloon sinus dilation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Balloon Sinus Dilation</title>
          <description>Balloon dilation of the maxillary sinus using a transnasal approach.&#xD;
Balloon sinus dilation</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Lund-Mackay score</title>
          <description>The Lund-Mackay score is a method for grading chronic rhinosinusitis using CT scans. The frontal, sphenoid, maxillary, anterior ethmoid, and posterior ethmoid sinus and the ostiomeatal complex on both sides are separately assigned scores of 0 (no abnormality), 1 (partial opacification), or 2 (complete opacification).&#xD;
The ostiomeatal complex is assigned a score of either 0 (not obstructed) or 2 (obstructed). The combined score can range from 0 to 24 with higher scores indicating more sinus disease.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.7" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Nonsmokers</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Smokers</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Allergies (year-round or seasonal)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>SNOT-20 Score</title>
        <description>The 20-item Sino-Nasal Outcomes Test (SNOT-20) is a validated patient-reported outcome measure for assessing the presence and severity of symptoms of chronic rhinosinusitis. Symptoms on the SNOT-20 survey are each rated on a scale from 0 (no problem) to 5 (problem as bad as it can be) and the 20 symptom scores are averaged to provide a total score ranging from 0 to 5. The minimal clinically important difference in the SNOT-20 has been determined to be a reduction greater or equal to 0.8 in the total SNOT-20 score.</description>
        <time_frame>Baseline and 6 months post procedure</time_frame>
        <population>All participants with baseline and 6-month follow-up SNOT-20 assessments (matched pairs).</population>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinus Dilation</title>
            <description>Balloon dilation of the maxillary sinus using a transnasal approach.&#xD;
Balloon sinus dilation</description>
          </group>
        </group_list>
        <measure>
          <title>SNOT-20 Score</title>
          <description>The 20-item Sino-Nasal Outcomes Test (SNOT-20) is a validated patient-reported outcome measure for assessing the presence and severity of symptoms of chronic rhinosinusitis. Symptoms on the SNOT-20 survey are each rated on a scale from 0 (no problem) to 5 (problem as bad as it can be) and the 20 symptom scores are averaged to provide a total score ranging from 0 to 5. The minimal clinically important difference in the SNOT-20 has been determined to be a reduction greater or equal to 0.8 in the total SNOT-20 score.</description>
          <population>All participants with baseline and 6-month follow-up SNOT-20 assessments (matched pairs).</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Month Follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>P values &lt;0.05 are considered statistically significant.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recovery Time</title>
        <description>Patient-reported time from procedure to ability to return to normal daily activities.</description>
        <time_frame>1 week post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinus Dilation</title>
            <description>Balloon dilation of the maxillary sinus using a transnasal approach.&#xD;
Balloon sinus dilation</description>
          </group>
        </group_list>
        <measure>
          <title>Recovery Time</title>
          <description>Patient-reported time from procedure to ability to return to normal daily activities.</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.1" spread="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Pain Scores</title>
        <description>Procedure pain/discomfort on a scale of 0 (no pain) to 10 (severe pain) as reported by the participant.</description>
        <time_frame>Immediately post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinus Dilation</title>
            <description>Balloon dilation of the maxillary sinus using a transnasal approach.&#xD;
Balloon sinus dilation</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Pain Scores</title>
          <description>Procedure pain/discomfort on a scale of 0 (no pain) to 10 (severe pain) as reported by the participant.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Revision Rate</title>
        <description>The number of participants who require revision sinus surgery during the study duration.</description>
        <time_frame>6 Months post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinus Dilation</title>
            <description>Balloon dilation of the maxillary sinus using a transnasal approach.&#xD;
Balloon sinus dilation</description>
          </group>
        </group_list>
        <measure>
          <title>Revision Rate</title>
          <description>The number of participants who require revision sinus surgery during the study duration.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months post procedure</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Balloon Sinus Dilation</title>
          <description>Balloon dilation of the maxillary sinus using a transnasal approach.&#xD;
Balloon sinus dilation</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Complication of diabetes mellitus</sub_title>
                <description>Participant was hospitalized for complications related to diabetes mellitus. The event is not related to the study device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Principal Clinical Research &amp; Publications Manager</name_or_title>
      <organization>Stryker ENT</organization>
      <phone>764-463-1598</phone>
      <email>ellen.omalley@stryker.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

